These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 28884871)

  • 21. Transforming growth factor-β activated long non-coding RNA ATB plays an important role in acute rejection of renal allografts and may impacts the postoperative pharmaceutical immunosuppression therapy.
    Qiu J; Chen Y; Huang G; Zhang Z; Chen L; Na N
    Nephrology (Carlton); 2017 Oct; 22(10):796-803. PubMed ID: 27414253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of lncRNA-ATB correlates with clinical progression and unfavorable prognosis in pancreatic cancer.
    Qu S; Yang X; Song W; Sun W; Li X; Wang J; Zhong Y; Shang R; Ruan B; Zhang Z; Zhang X; Li H
    Tumour Biol; 2016 Mar; 37(3):3933-8. PubMed ID: 26482611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
    Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
    J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA-ATB Promotes Lung Squamous Carcinoma Cell Proliferation, Migration, and Invasion by Targeting microRNA-590-5p/NF90 Axis.
    Li J; Xia R; Liu T; Cai X; Geng G
    DNA Cell Biol; 2020 Mar; 39(3):459-473. PubMed ID: 31934791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma.
    Yuan JH; Yang F; Wang F; Ma JZ; Guo YJ; Tao QF; Liu F; Pan W; Wang TT; Zhou CC; Wang SB; Wang YZ; Yang Y; Yang N; Zhou WP; Yang GS; Sun SH
    Cancer Cell; 2014 May; 25(5):666-81. PubMed ID: 24768205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 27. CCAT1: a pivotal oncogenic long non-coding RNA in human cancers.
    Xin Y; Li Z; Shen J; Chan MT; Wu WK
    Cell Prolif; 2016 Jun; 49(3):255-60. PubMed ID: 27134049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
    Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
    Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
    Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
    Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA-ATB in cancers: what do we know so far?
    Tang F; Xu Y; Wang H; Bian E; Zhao B
    Mol Biol Rep; 2020 May; 47(5):4077-4086. PubMed ID: 32248383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer.
    Xu F; Zhang J
    Biomed Pharmacother; 2017 Jun; 90():888-896. PubMed ID: 28441714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
    Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
    DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
    Song R; Zhang J; Huang J; Hai T
    Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.
    Li Z; Yu X; Shen J
    Tumour Biol; 2016 May; 37(5):5657-61. PubMed ID: 26753962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding SNHG1 in cancer.
    Thin KZ; Tu JC; Raveendran S
    Clin Chim Acta; 2019 Jul; 494():38-47. PubMed ID: 30849309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression.
    Zhang Y; Li J; Jia S; Wang Y; Kang Y; Zhang W
    Biochem Cell Biol; 2019 Apr; 97(2):193-200. PubMed ID: 30352165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
    El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
    Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA-ATB promotes apoptosis of non-small cell lung cancer cells through MiR-200a/β-Catenin.
    Wang T; Tang X; Liu Y
    J BUON; 2019; 24(6):2280-2286. PubMed ID: 31983095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.